TuHURA Biosciences Financials
| HURA Stock | 4.48 0.48 12.00% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1564 |
|
|
The financial analysis of TuHURA Biosciences is a critical element in measuring its lifeblood. Investors should not minimize TuHURA Biosciences' ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
TuHURA | Select Account or Indicator |
Understanding current and past TuHURA Biosciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of TuHURA Biosciences' financial statements are interrelated, with each one affecting the others. For example, an increase in TuHURA Biosciences' assets may result in an increase in income on the income statement.
Please note, the presentation of TuHURA Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, TuHURA Biosciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of TuHURA Biosciences' management manipulating its earnings.
TuHURA Biosciences Stock Summary
TuHURA Biosciences competes with Dogwood Therapeutics,, Opus Genetics,, and Telix Pharmaceuticals. TuHURA Biosciences is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Healthcare, Biotechnology |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 49720K101 247078207 49720K200 247078306 247078108 898920103 |
| Older Symbol | KTRA |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
TuHURA Biosciences Key Financial Ratios
| EBITDA | (29.12 M) | ||||
| Net Income | (29.32 M) | ||||
| Market Capitalization | 141.65 M | ||||
| Total Asset | 4.36 M | ||||
| Retained Earnings | (88.47 M) |
TuHURA Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining TuHURA Biosciences's current stock value. Our valuation model uses many indicators to compare TuHURA Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across TuHURA Biosciences competition to find correlations between indicators driving TuHURA Biosciences's intrinsic value. More Info.TuHURA Biosciences is rated # 2 in current valuation category among its peers. It also is rated # 2 in shares outstanding category among its peers creating about 0.13 of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for TuHURA Biosciences is roughly 7.45 . The current year's Common Stock Shares Outstanding is expected to grow to about 71.4 M. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the TuHURA Biosciences' earnings, one of the primary drivers of an investment's value.TuHURA Biosciences Systematic Risk
TuHURA Biosciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. TuHURA Biosciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on TuHURA Biosciences correlated with the market. If Beta is less than 0 TuHURA Biosciences generally moves in the opposite direction as compared to the market. If TuHURA Biosciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one TuHURA Biosciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of TuHURA Biosciences is generally in the same direction as the market. If Beta > 1 TuHURA Biosciences moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in TuHURA Biosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various TuHURA Biosciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of TuHURA Biosciences growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
TuHURA Biosciences December 21, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of TuHURA Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of TuHURA Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of TuHURA Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing TuHURA Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build TuHURA Biosciences's daily price indicators and compare them against related drivers.
| Downside Deviation | 9.13 | |||
| Information Ratio | 7.0E-4 | |||
| Maximum Drawdown | 60.72 | |||
| Value At Risk | (15.55) | |||
| Potential Upside | 15.48 |
Complementary Tools for TuHURA Stock analysis
When running TuHURA Biosciences' price analysis, check to measure TuHURA Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TuHURA Biosciences is operating at the current time. Most of TuHURA Biosciences' value examination focuses on studying past and present price action to predict the probability of TuHURA Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TuHURA Biosciences' price. Additionally, you may evaluate how the addition of TuHURA Biosciences to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |